MedPath

Tetracycline

Generic Name
Tetracycline
Brand Names
Pylera, Sumycin
Drug Type
Small Molecule
Chemical Formula
C22H24N2O8
CAS Number
60-54-8
Unique Ingredient Identifier
F8VB5M810T

Overview

Tetracycline is a broad spectrum polyketide antibiotic produced by the Streptomyces genus of Actinobacteria. It exerts a bacteriostatic effect on bacteria by binding reversible to the bacterial 30S ribosomal subunit and blocking incoming aminoacyl tRNA from binding to the ribosome acceptor site. It also binds to some extent to the bacterial 50S ribosomal subunit and may alter the cytoplasmic membrane causing intracellular components to leak from bacterial cells. The FDA withdrew its approval for the use of all liquid oral drug products formulated for pediatric use containing tetracycline in a concentration greater than 25 mg/ml. Other formulations of tetracycline continue to be used.

Background

Tetracycline is a broad spectrum polyketide antibiotic produced by the Streptomyces genus of Actinobacteria. It exerts a bacteriostatic effect on bacteria by binding reversible to the bacterial 30S ribosomal subunit and blocking incoming aminoacyl tRNA from binding to the ribosome acceptor site. It also binds to some extent to the bacterial 50S ribosomal subunit and may alter the cytoplasmic membrane causing intracellular components to leak from bacterial cells. The FDA withdrew its approval for the use of all liquid oral drug products formulated for pediatric use containing tetracycline in a concentration greater than 25 mg/ml. Other formulations of tetracycline continue to be used.

Indication

Used to treat bacterial infections such as Rocky Mountain spotted fever, typhus fever, tick fevers, Q fever, rickettsialpox and Brill-Zinsser disease. May be used to treat infections caused by Chlamydiae spp., B. burgdorferi (Lyme disease), and upper respiratory infections caused by typical (S. pneumoniae, H. influenzae, and M. catarrhalis) and atypical organisms (C. pneumoniae, M. pneumoniae, L. pneumophila). May also be used to treat acne. Tetracycline may be an alternative drug for people who are allergic to penicillin.

Associated Conditions

  • Acinetobacter Infections
  • Actinomycosis
  • Anthrax
  • Bacterial Infections
  • Bartonellosis
  • Brucellosis
  • Campylobacter Infection
  • Chancroid
  • Chlamydial Infections
  • Cholera (Disorder)
  • Clostridium Infections
  • Conjunctivitis, Inclusion
  • Cystitis
  • Endometritis
  • Entamoebic histolytica infection
  • Escherichia infections
  • Granuloma Inguinale
  • Helicobacter Pylori Infection
  • Infection
  • Infection, Bacteroides
  • Klebsiella Infections
  • Listeria infection
  • Lower respiratory tract infection bacterial
  • Lymphogranuloma Venereum
  • Necrotizing ulcerative gingivostomatitis
  • Neisseria Gonorrhoeae Infection
  • Nephritis
  • Ornithosis
  • Plague
  • Prostatitis
  • Psittacosis
  • Q Fever
  • Relapsing Fever
  • Rickettsialpox
  • Rocky Mountain Spotted Fever
  • Rosacea
  • Severe Acne
  • Shigella Infection
  • Skin Infections caused by Staphylococcus Aureus
  • Skin and Subcutaneous Tissue Bacterial Infections
  • Syphilis
  • Trachoma
  • Tularemia
  • Typhus
  • Upper respiratory tract infection bacterial
  • Urinary Tract Infection
  • Yaws
  • Grade 1, grade 2, grade 3, grade 4 Urinary Tract Infection

FDA Approved Products

Tetracycline Hydrochloride
Manufacturer:Chartwell RX, LLC.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2023/07/19
NDC:62135-266
Tetracycline Hydrochloride
Manufacturer:Breckenridge Pharmaceutical, Inc.
Route:ORAL
Strength:250 mg in 1 1
Approved: 2024/02/08
NDC:51991-906
Tetracycline Hydrochloride
Manufacturer:Breckenridge Pharmaceutical, Inc.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2024/02/08
NDC:51991-907
Tetracycline Hydrochloride
Manufacturer:Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2020/03/31
NDC:23155-767
TETRACYCLINE HYDROCHLORIDE
Manufacturer:Strides Pharma Science Limited
Route:ORAL
Strength:250 mg in 1 1
Approved: 2022/10/21
NDC:64380-890

Singapore Approved Products

BEATACYCLINE CAPSULE 250 mg
Manufacturer:BEACONS PHARMACEUTICALS PTE. LTD.
Form:CAPSULE
Strength:250 mg
Online:Yes
Approved: 1988/06/24
Approval:SIN02053P
TETRACYCLINE MC CAPSULE 250 mg
Manufacturer:MEDOCHEMIE LTD - FACTORY AZ
Form:CAPSULE
Strength:250 mg
Online:Yes
Approved: 1988/05/10
Approval:SIN00969P
BIOTINE OINTMENT 3% w/w
Manufacturer:ICM PHARMA PTE. LTD.
Form:OINTMENT
Strength:3% w/w
Online:Yes
Approved: 1996/01/05
Approval:SIN08514P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath